Mishal Mendiratta-Lala
Professor of Radiology
Radiology
1500 East Medical Center Drive
Ann Arbor, MI 48019
[email protected]

Available to mentor

Mishal Mendiratta-Lala
Clinical Professor
  • About
  • Research Overview
  • Recent Publications
  • About

    Dr. Mishal Mendiratta-Lala earned her B.S. in Health Sciences from Kalamazoo College in 2000. She earned her MD from Wayne State University School of Medicine in 2004. She went on to perform her residency in Diagnostic Radiology at Henry Ford Hospital in Detroit, Michigan. Following this she performed a Fellowship within Abdominal Radiology at Beth Israel Deaconess Hospital at Harvard University in 2009. in 2010 she became a Clinical Assistant Professor of Radiology at Wayne State University School of Medicine and a Senior Staff Physician at Henry Ford Hospital in Detroit, Michigan. She would go on to become a Clinical Assistant Professor within the Department of Radiology at Michigan Medicine in 2015 and later would become an Associate Professor in the Department of Radiology in 2018. She has serves as the Co-Director of Interventional Oncology within the Department of Radiology at the University of Michigan since 2021 as well as the Director of Abdominal MRI within the department of Radiology at the University of Michigan.

    Research Overview

    cross-sectional interventional procedures, interventional oncology, hepatocellular carcinoma diagnosis, staging, and treatment response, histotripsy and locoablative therapy, MR Imaging, hepatobiliary imaging

    Recent Publications See All Publications
    • Journal Article
      Insights from in vivo preclinical cancer studies with histotripsy.
      Worlikar T, Hall T, Zhang M, Mendiratta-Lala M, Green M, Cho CS, Xu Z. Int J Hyperthermia, 2024 41 (1): 2297650 DOI:10.1080/02656736.2023.2297650
      PMID: 38214171
    • Journal Article
      AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
      Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH. Hepatology, 2023 Dec 1; 78 (6): 1922 - 1965. DOI:10.1097/HEP.0000000000000466
      PMID: 37199193
    • Journal Article
      Efficacy of a Second Course of Radiation for Patients With Metachronous Hepatocellular Carcinoma.
      Gharzai LA, Wang C, Tang M, Jackson WC, Maurino C, Cousins MM, Mendiratta-Lala M, Parikh ND, Mayo CS, Haken RKT, Owen D, Cuneo KC, Schipper MJ, Lawrence TS. Pract Radiat Oncol, 2023 13 (6): e504 - e514. DOI:10.1016/j.prro.2023.05.008
      PMID: 37295727
    • Journal Article
      Society of abdominal radiology survey of practice patterns in using LI-RADS treatment response criteria in the evaluation of hepatocellular carcinoma post-locoregional treatment.
      Kampalath R, Mendiratta-Lala M, Lewis S, Benefield T, Yaghmai V, Burke L. Abdom Radiol (NY), 2023 Nov; 48 (11): 3401 - 3407. DOI:10.1007/s00261-023-04022-9
      PMID: 37658876
    • Journal Article
      A Phase II Study of Optimized Individualized Adaptive Radiotherapy for Hepatocellular Carcinoma.
      Herr DJ, Wang C, Mendiratta-Lala M, Matuszak M, Mayo CS, Cao Y, Parikh ND, Ten Haken R, Owen D, Evans JR, Stanescu T, Yan M, Dawson LA, Schipper M, Lawrence TS, Cuneo KC. Clin Cancer Res, 2023 Oct 2; 29 (19): 3852 - 3858. DOI:10.1158/1078-0432.CCR-23-1044
      PMID: 37471457
    • Journal Article
      A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.
      Hong CW, Chernyak V, Choi J-Y, Lee S, Potu C, Delgado T, Wolfson T, Gamst A, Birnbaum J, Kampalath R, Lall C, Lee JT, Owen JW, Aguirre DA, Mendiratta-Lala M, Davenport MS, Masch W, Roudenko A, Lewis SC, Kierans AS, Hecht EM, Bashir MR, Brancatelli G, Douek ML, Ohliger MA, Tang A, Cerny M, Fung A, Costa EA, Corwin MT, McGahan JP, Kalb B, Elsayes KM, Surabhi VR, Blair K, Marks RM, Horvat N, Best S, Ash R, Ganesan K, Kagay CR, Kambadakone A, Wang J, Cruite I, Bijan B, Goodwin M, Moura Cunha G, Tamayo-Murillo D, Fowler KJ, Sirlin CB. Radiology, 2023 Jun; 307 (5): e222855 DOI:10.1148/radiol.222855
      PMID: 37367445
    • Journal Article
      Erratum for: A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.
      Hong CW, Chernyak V, Choi J-Y, Lee S, Potu C, Delgado T, Wolfson T, Gamst A, Birnbaum J, Kampalath R, Lall C, Lee JT, Owen JW, Aguirre DA, Mendiratta-Lala M, Davenport MS, Masch W, Roudenko A, Lewis SC, Kierans AS, Hecht EM, Bashir MR, Brancatelli G, Douek ML, Ohliger MA, Tang A, Cerny M, Fung A, Costa EA, Corwin MT, McGahan JP, Kalb B, Elsayes KM, Surabhi VR, Blair K, Marks RM, Horvat N, Best S, Ash R, Ganesan K, Kagay CR, Kambadakone A, Wang J, Cruite I, Bijan B, Goodwin M, Cunha GM, Tamayo-Murillo D, Fowler KJ, Sirlin CB. Radiology, 2023 Jul; 308 (1): e239018 DOI:10.1148/radiol.239018
      PMID: 37489994
    • Journal Article
      Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study.
      Moon AM, Kim HP, Singal AG, Owen D, Mendiratta-Lala M, Parikh ND, Rose SC, McGinty KA, Agala CB, Burke LM, Abate A, Altun E, Beyer C, Do J, Folkert MR, Forbes C, Hattangadi-Gluth JA, Hayashi PH, Jones K, Khatri G, Kono Y, Lawrence TS, Maurino C, Mauro DM, Mayo CS, Pak T, Patil P, Sanders EC, Simpson DR, Tepper JE, Thapa D, Yanagihara TK, Wang K, Gerber DA. Hepatol Commun, 2023 Jul 1; 7 (7): DOI:10.1097/HC9.0000000000000184
      PMID: 37314737
    Featured News & Stories machine beige black
    Health Lab
    Histotripsy liver tumor trial successful, early clinical adoption recommended
    The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert explains more about it in this article.